Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

Efficient and rapid synthesis of 1,2,3-triazole derivatives has been achieved via Huisgen's 1,3-dipolar cycloaddition between alkyl/arylazides and diethyl/dimethyl acetylenedicarboxylate in excellent yields under solvent-free conditions. The environmentally friendly solvent-free protocol overcomes the limitations associated with the prevailing time-consuming solution phase protocols and affords the triazoles just in 1-3 min. In vitro antitubercular activity of these triazoles was screened against Mycobacterium tuberculosis H(37)Rv strain. Four of the compounds showed MIC in the range of 1.56-3.13 μg/mL proving their potential activity.

Knowledge Graph

Similar Paper

Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2011.0
Application of Huisgen (3+2) cycloaddition reaction: Synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations
European Journal of Medicinal Chemistry 2010.0
Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents
Bioorganic & Medicinal Chemistry Letters 2019.0
Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2- b ]pyridine-1,2,3-triazole derivatives
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents
Bioorganic & Medicinal Chemistry Letters 2017.0
1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study
MedChemComm 2015.0
A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain
Journal of Medicinal Chemistry 2011.0
Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv
European Journal of Medicinal Chemistry 2010.0